Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Ferrantelli

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of the American Society of Nephrology : JASN|March 2, 2021
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized TrialFrancesco Scolari, Elisa Delbarba, Domenico Santoro, et al.
Kidney International Reports|August 15, 2022
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the AdultMartina Tedesco, Federica Mescia, Isabella Pisani, et al.
Kidney International Reports|May 25, 2026
Missing Opportunity for Nephroprotective Therapy in Patients With Non-Dialysis CKD Under Stable Nephrology CareLuca De Nicola, Chiara Ruotolo, Gaetano La Manna, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2022
The risks associated with percutaneous native kidney biopsies: a prospective studySimeone Andrulli, Michele Rossini, Giuseppe Gigliotti, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of the American Society of Nephrology : JASN|March 2, 2021
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized TrialFrancesco Scolari, Elisa Delbarba, Domenico Santoro, et al.
Kidney International Reports|August 15, 2022
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the AdultMartina Tedesco, Federica Mescia, Isabella Pisani, et al.
Kidney International Reports|May 25, 2026
Missing Opportunity for Nephroprotective Therapy in Patients With Non-Dialysis CKD Under Stable Nephrology CareLuca De Nicola, Chiara Ruotolo, Gaetano La Manna, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2022
The risks associated with percutaneous native kidney biopsies: a prospective studySimeone Andrulli, Michele Rossini, Giuseppe Gigliotti, et al.
Pageof 2